TrialBMJ open2021

Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy.

Chinmayi Himanshuroy Vyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.